Skip navigation

DSpace

機構典藏 DSpace 系統致力於保存各式數位資料(如:文字、圖片、PDF)並使其易於取用。

點此認識 DSpace
DSpace logo
English
中文
  • 瀏覽論文
    • 校院系所
    • 出版年
    • 作者
    • 標題
    • 關鍵字
    • 指導教授
  • 搜尋 TDR
  • 授權 Q&A
    • 我的頁面
    • 接受 E-mail 通知
    • 編輯個人資料
  1. NTU Theses and Dissertations Repository
  2. 生命科學院
  3. 生化科技學系
請用此 Handle URI 來引用此文件: http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/19749
完整後設資料紀錄
DC 欄位值語言
dc.contributor.advisor廖憶純(Yi-Chun Liao)
dc.contributor.authorYen-kang Huangen
dc.contributor.author黃彥康zh_TW
dc.date.accessioned2021-06-08T02:16:56Z-
dc.date.copyright2015-12-01
dc.date.issued2015
dc.date.submitted2015-10-16
dc.identifier.citation五、 參考文獻
李昌恆, (2014) 探討 Cten 與 beta-catenin 和 alpha-actinin4 之間的交互作用極 Cten 於細胞質核細胞核間穿梭的機制,國立台灣大學生命科學院生化科技學系
Al-Ghamdi, S., A. Albasri, J. Cachat, S. Ibrahem, B. A. Muhammad, D. Jackson, A. S. Nateri, K. B. Kindle and M. Ilyas (2011). 'Cten is targeted by Kras signalling to regulate cell motility in the colon and pancreas.' PLoS One 6(6): e20919.
Albasri, A., M. Aleskandarany, A. Benhasouna, D. G. Powe, I. O. Ellis, M. Ilyas and A. R. Green (2011). 'CTEN (C-terminal tensin-like), a novel oncogene overexpressed in invasive breast carcinoma of poor prognosis.' Breast Cancer Res Treat 126(1): 47-54.
Brauer, P. M., Y. Zheng, L. Wang and A. L. Tyner (2010). 'Cytoplasmic retention of protein tyrosine kinase 6 promotes growth of prostate tumor cells.' Cell Cycle 9(20): 4190-4199.
Chen, H., I. C. Duncan, H. Bozorgchami and S. H. Lo (2002). 'Tensin1 and a previously undocumented family member, tensin2, positively regulate cell migration.' Proc Natl Acad Sci U S A 99(2): 733-738.
Chiang, M. K., Y. C. Liao, Y. Kuwabara and S. H. Lo (2005). 'Inactivation of tensin3 in mice results in growth retardation and postnatal lethality.' Dev Biol 279(2): 368-377.
Clevers, H. (2006). 'Wnt/beta-catenin signaling in development and disease.' Cell 127(3): 469-480.
Cross, F. R., E. A. Garber and H. Hanafusa (1985). 'N-terminal deletions in Rous sarcoma virus p60src: effects on tyrosine kinase and biological activities and on recombination in tissue culture with the cellular src gene.' Mol Cell Biol 5(10): 2789-2795.
De Vita, G., M. T. Berlingieri, R. Visconti, M. D. Castellone, G. Viglietto, G. Baldassarre, M. Zannini, A. Bellacosa, P. N. Tsichlis, A. Fusco and M. Santoro (2000). 'Akt/protein kinase B promotes survival and hormone-independent proliferation of thyroid cells in the absence of dedifferentiating and transforming effects.' Cancer Res 60(14): 3916-3920.
Duperret, E. K. and T. W. Ridky (2013). 'Focal adhesion complex proteins in epidermis and squamous cell carcinoma.' Cell Cycle 12(20): 3272-3285.
Giles, R. H., J. H. van Es and H. Clevers (2003). 'Caught up in a Wnt storm: Wnt signaling in cancer.' Biochim Biophys Acta 1653(1): 1-24.
Gonzalo, S. and M. E. Linder (1998). 'SNAP-25 palmitoylation and plasma membrane targeting require a functional secretory pathway.' Mol Biol Cell 9(3): 585-597.
Gravina, G. L., W. Senapedis, D. McCauley, E. Baloglu, S. Shacham and C. Festuccia (2014). 'Nucleo-cytoplasmic transport as a therapeutic target of cancer.' J Hematol Oncol 7: 85.
Gumbiner, B. M. (1996). 'Cell adhesion: the molecular basis of tissue architecture and morphogenesis.' Cell 84(3): 345-357.
Hill, R., B. Cautain, N. de Pedro and W. Link (2014). 'Targeting nucleocytoplasmic transport in cancer therapy.' Oncotarget 5(1): 11-28.
Ishii, A. and S. H. Lo (2001). 'A role of tensin in skeletal-muscle regeneration.' Biochem J 356(Pt 3): 737-745.
Jans, D. A., C. Y. Xiao and M. H. Lam (2000). 'Nuclear targeting signal recognition: a key control point in nuclear transport?' Bioessays 22(6): 532-544.
Katz, M., I. Amit, A. Citri, T. Shay, S. Carvalho, S. Lavi, F. Milanezi, L. Lyass, N. Amariglio, J. Jacob-Hirsch, N. Ben-Chetrit, G. Tarcic, M. Lindzen, R. Avraham, Y. C. Liao, P. Trusk, A. Lyass, G. Rechavi, N. L. Spector, S. H. Lo, F. Schmitt, S. S. Bacus and Y. Yarden (2007). 'A reciprocal tensin-3-cten switch mediates EGF-driven mammary cell migration.' Nat Cell Biol 9(8): 961-969.
Li, C., M. Iida, E. F. Dunn, A. J. Ghia and D. L. Wheeler (2009). 'Nuclear EGFR contributes to acquired resistance to cetuximab.' Oncogene 28(43): 3801-3813.
Liao, Y. C., N. T. Chen, Y. P. Shih, Y. Dong and S. H. Lo (2009). 'Up-regulation of C-terminal tensin-like molecule promotes the tumorigenicity of colon cancer through beta-catenin.' Cancer Res 69(11): 4563-4566.
Liu, Y., D. A. Fisher and D. R. Storm (1994). 'Intracellular sorting of neuromodulin (GAP-43) mutants modified in the membrane targeting domain.' J Neurosci 14(10): 5807-5817.
Lo, S. H. (2004). 'Tensin.' Int J Biochem Cell Biol 36(1): 31-34.
Lo, S. H. and T. B. Lo (2002). 'Cten, a COOH-terminal tensin-like protein with prostate restricted expression, is down-regulated in prostate cancer.' Cancer Res 62(15): 4217-4221.
Lo, S. H., Q. C. Yu, L. Degenstein, L. B. Chen and E. Fuchs (1997). 'Progressive kidney degeneration in mice lacking tensin.' J Cell Biol 136(6): 1349-1361.
Owen, G. R., D. O. Meredith, I. ap Gwynn and R. G. Richards (2005). 'Focal adhesion quantification - a new assay of material biocompatibility? Review.' Eur Cell Mater 9: 85-96; discussion 85-96.
Resh, M. D. (1994). 'Myristylation and palmitylation of Src family members: the fats of the matter.' Cell 76(3): 411-413.
Resh, M. D. (1999). 'Fatty acylation of proteins: new insights into membrane targeting of myristoylated and palmitoylated proteins.' Biochim Biophys Acta 1451(1): 1-16.
Robbins, J., S. M. Dilworth, R. A. Laskey and C. Dingwall (1991). 'Two interdependent basic domains in nucleoplasmin nuclear targeting sequence: identification of a class of bipartite nuclear targeting sequence.' Cell 64(3): 615-623.
Sasaki, H., S. Moriyama, K. Mizuno, H. Yukiue, A. Konishi, M. Yano, M. Kaji, I. Fukai, M. Kiriyama, Y. Yamakawa and Y. Fujii (2003). 'Cten mRNA expression was correlated with tumor progression in lung cancers.' Lung Cancer 40(2): 151-155.
Sasaki, H., H. Yukiue, Y. Kobayashi, I. Fukai and Y. Fujii (2003). 'Cten mRNA expression is correlated with tumor progression in thymoma.' Tumour Biol 24(5): 271-274.
Shangary, S. and S. Wang (2009). 'Small-molecule inhibitors of the MDM2-p53 protein-protein interaction to reactivate p53 function: a novel approach for cancer therapy.' Annu Rev Pharmacol Toxicol 49: 223-241.
Sorokin, A. V., E. R. Kim and L. P. Ovchinnikov (2007). 'Nucleocytoplasmic transport of proteins.' Biochemistry (Mosc) 72(13): 1439-1457.
Timmers, A. C., R. Stuger, P. J. Schaap, J. van 't Riet and H. A. Raue (1999). 'Nuclear and nucleolar localization of Saccharomyces cerevisiae ribosomal proteins S22 and S25.' FEBS Lett 452(3): 335-340.
Werneburg, B. G., S. J. Zoog, T. T. Dang, M. R. Kehry and J. J. Crute (2001). 'Molecular characterization of CD40 signaling intermediates.' J Biol Chem 276(46): 43334-43342.
Wright, M. H., W. P. Heal, D. J. Mann and E. W. Tate (2010). 'Protein myristoylation in health and disease.' J Chem Biol 3(1): 19-35.
Wu, C. (2007). 'Focal adhesion: a focal point in current cell biology and molecular medicine.' Cell Adh Migr 1(1): 13-18.
dc.identifier.urihttp://tdr.lib.ntu.edu.tw/jspui/handle/123456789/19749-
dc.description.abstract摘要
C-terminal tensin-like (CTEN) 為位於 focal adhesion 上tensin 家族的一員,除了前列腺和胎盤組織外,在其他正常組織中表現不多,但是在許多的癌症,如肺癌、大腸癌以及乳癌中卻有表現量上升的情況,除了 focal adhesion,CTEN在大腸癌細胞株 SW480 與 HCT 116 中有在核內累積的現象。在細胞核中大量存在的 CTEN 也被證實會和 Wnt pathway 中的 beta-catenin 結合並促進腫瘤發生。另一方面,若在正常的人類腎臟胚胎細胞 293A 與正常的前列腺細胞 RWPE-1 表現 CTEN,則會在細胞質內分布較多,顯示 CTEN 在細胞內的位置與細胞癌化的高度相關性。本論文假設 CTEN 在核內的累積會促使細胞癌化。藉由在 CTEN 蛋白質上加上 nucleus localization signal (NLS) 或 Src myristoylation signal,改變 CTEN 在細胞內的分布,並了解 CTEN 分布的差異對細胞癌化特性的影響。首先建立穩定表現帶有特殊胺基酸訊號 (NLS signal and Src myristoylation signal) 的 CTEN 蛋白質之細胞株,以西方墨點法 (western blot) 與免疫螢光法 (immunofluorescence) 確認在細胞內表現含不同訊號的CTEN 時,確實會導致 CTEN 在細胞內的分布有相對應的改變。接著以 cell proliferation assay 初步觀察不同 CTEN 分佈對細胞生理的影響,發現 CTEN 於細胞核內累積並不影響細胞生長速率。
zh_TW
dc.description.abstractC-terminal tensin-like (CTEN) locates in focal adhesion and belongs to tensin family. CTEN expresses much in prostate and placenta, but rarely expresses in other normal tissues. Elevated CTEN level has been detected in lung cancer, colorectal cancer and breast cancer. In addition to focal adhesion, CTEN also accumulates in the nucleus in colorectal cancer cell lines SW480 and HCT 116. It has been found that CTEN in nucleus interacts with Wnt pathway signal beta-catenin and promotes tumorigenesis. On the other hand, human kidney embryonic cell 293A and normal prostate cell RWPE-1 express CTEN predominantly in cytoplasm. It is shown that CTEN localization is related to tumorigenesis. We assumpted that CTEN accumulation in the nucleus will lead to tumor. By adding special signaling amino acid sequence, nucleus localization signal (NLS) and Src myristoylation signal cause CTEN to change localization in cell. Therefore, we can observe tumorigenesis of cells with different CTEN localization. First, we established stable cell lines expressing CTEN protein with special amino acid signals. We checked with western blot and immunofluorescence, and we confirmed that expressing CTEN with different signals does cause CTEN distribution changes. Then, we used cell proliferation assay to observe the effect of CTEN distribution in tumorigenesis, and we found that CTEN accumulation in cell nucleus do not affect cell proliferation rate.en
dc.description.provenanceMade available in DSpace on 2021-06-08T02:16:56Z (GMT). No. of bitstreams: 1
ntu-104-R02b22005-1.pdf: 2395478 bytes, checksum: 5a8e391bd409074453dfc252d90a5495 (MD5)
Previous issue date: 2015
en
dc.description.tableofcontents目錄
目錄 I
縮寫表 IV
摘要 VI
Abstract VII
一、 研究背景 1
1.1 Focal adhesion 1
1.2 Tensin 2
1.3 CTEN 與癌症 2
1.4 蛋白質進出和與癌症的關係 3
1.5 協助蛋白質定位的特殊胺基酸序列 5
1.5.1 Membrane-targeting signaling sequence ──Src myristoylation 5
1.5.2 Nucleus-targeting signaling sequence ── Nuclear localization sequence (NLS) 6
1.6 研究目的 8
二、材料與方法 9
2.1 細胞培養 9
2.2 細胞繼代 9
2.3 細胞之冷凍與解凍 10
2.4 細胞計數 10
2.5 細胞轉染 11
2.6 表現 CTEN 的質體 DNA 建構與分析 11
2.6.1 聚合酶連鎖反應 (PCR) 11
2.6.2 DNA 片段純化 12
2.6.3 以限制酶截切質體與PCR產物 12
2.6.4 DNA 接合法 (DNA ligation) 12
2.6.5 重組質體之轉型與篩選 12
2.6.6 質體純化 13
2.6.7 以限制酶進行質體分析 13
2.6.8 DNA 瓊脂糖膠體電泳法 13
2.7 細胞全蛋白質之抽取 13
2.8 細胞質與細胞核萃取液分離 (fractionation) 14
2.9 蛋白質分析 14
2.9.1 蛋白質定量 14
2.9.2 聚丙烯醯胺膠體電泳 14
2.9.3 Coomassie Brilliant Blue (CBR) 染色法 15
2.9.4 蛋白質轉印 15
2.9.5 免疫呈色法 15
2.10 螢光染色 16
2.11 篩選穩定表現細胞株 16
2.12 Cell proliferation assay 17

三、研究結果 18
3.1 帶有特殊胺基酸訊號之 CTEN 在細胞內的分佈 18
3.2 重新建構帶有進核特殊胺基酸序列的 NLS-CTEN 20
3.3 建立穩定表現含不同訊息胺基酸序列 CTEN 的細胞株 20
3.4 確認 CTEN 在各組細胞株中的分佈 22
3.5 分析 CTEN 在細胞核的分佈是否影響細胞增生 23
四、討論與未來方向 24
五、參考文獻 28
六、圖與表 31
dc.language.isozh-TW
dc.title細胞核中的 CTEN 於腫瘤發生過程中所扮演的角色zh_TW
dc.titleThe Role of Nuclear CTEN in Tumorigenesisen
dc.typeThesis
dc.date.schoolyear104-1
dc.description.degree碩士
dc.contributor.oralexamcommittee黃楓婷(Feng-Ting Huang),謝淑貞(Shu-Chen Hsieh),賴韻如(Yun-Ju Lai)
dc.subject.keyword腫瘤發生,與細胞膜結合,進核,癌症,蛋白質分佈,細胞生長速率,zh_TW
dc.subject.keywordTumorigenesis,CTEN,tensin,distribution,localization,cancer,tumor,membrane-targeting,nucleus-targeting,cell proliferation rate,en
dc.relation.page55
dc.rights.note未授權
dc.date.accepted2015-10-16
dc.contributor.author-college生命科學院zh_TW
dc.contributor.author-dept生化科技學系zh_TW
顯示於系所單位:生化科技學系

文件中的檔案:
檔案 大小格式 
ntu-104-1.pdf
  未授權公開取用
2.34 MBAdobe PDF
顯示文件簡單紀錄


系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。

社群連結
聯絡資訊
10617臺北市大安區羅斯福路四段1號
No.1 Sec.4, Roosevelt Rd., Taipei, Taiwan, R.O.C. 106
Tel: (02)33662353
Email: ntuetds@ntu.edu.tw
意見箱
相關連結
館藏目錄
國內圖書館整合查詢 MetaCat
臺大學術典藏 NTU Scholars
臺大圖書館數位典藏館
本站聲明
© NTU Library All Rights Reserved